Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction

Atherosclerosis

Volumn 147, Issue 2, 1999, Pages 317-326

  Christensen, B ^a   Landaas, S ^a   Stensvold, I ^a   Djurovic, S ^a   Retterstol L ^a   Ringstad, J ^b   Berg, K ^a   Thelle, D S ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Østfold Central Hospital   (Norway)

Author keywords

Folate; Homocysteine; Myocardial infarction; Smoking

Indexed keywords

APOLIPOPROTEIN A1; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE;

ACUTE HEART INFARCTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0032739895     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00202-6     Document Type: Article

References (52)

1. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
2. Berg K., Malinow M., Kierulf P., Upson B. Population variation and genetics of plasma homocyst(e)ine level. Clin Genet. 4:1992;315-321.
3. Christensen B., Frosst P., Lussier-Cacan S. et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol. 17:1997;569-573.
4. Jacobsen D.W., Gatautis V.J., Green R. et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem. 40:1994;873-881.
5. Arnesen E., Refsum H., Bonaa K.H., Ueland P.M., Forde O.H., Nordrehaug J.E. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 24:1995;704-709.
6. Nygård O., Refsum H., Ueland P.M., Vollset S.E. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr. 67:1998;263-270.
7. Robinson K., Arheart K., Refsum H. et al. Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation. 97:1998;437-443.
8. Rimm E.B., Willett W.C., Hu F.B. et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc. 279:1998;359-364.
9. Verhoef P., Stampfer M.J., Buring J.E. et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 143:1996;845-859.
10. Giles W.H., Kittner S.J., Croft J.B., Anda R.F., Casper M.L., Ford E.S. Serum folate and risk for coronary heart disease: results from a cohort of US adults. Ann Epidemiol. 8:1998;490-496.
11. Siri P.W., Verhoef P., Kok F.J. Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J Am Coll Nutr. 17:1998;435-441.
12. Verhoef P., Kok F.J., Kruyssen D.A. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;989-995.
13. Hirano K., Ogihara T., Miki M. et al. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Radic Res. 21:1994;267-276.
14. Araki A., Sako Y., Fukushima Y., Matsumoto M., Asada T., Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 79:1989;139-146.
15. Kang S.-S., Wong P.W.K., Cook H.Y., Norusis M., Messer J.V. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest. 77:1986;1482-1486.
16. Nygard O., Vollset S.E., Refsum H. et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 274:1995;1526-1533.
17. O'Brien T., Nguyen T.T., Hallaway B.J. et al. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease. Arterioscler Thromb Vasc Biol. 15:1995;228-231.
18. Ubbink J.B., Vermaak W.J.H., Bissbort S. Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum. J Chromatogr. 565:1991;441-446.
19. Frost-Andersen L., Solvoll K., Drevon C.A. Very long chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr. 64:1996;305-311.
20. Nes M., Frost Andersen L., Solvoll K. et al. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women. Eur J Clin Nutr. 46:1992;809-821.
21. Solvoll K., Lund-Larsen K., S¢yland E., Sandstad B., Drevon C.A. A quantitative food frequency questionnaire evaluated in a group of dermatologic outpatients. Scand J Nutr/Näringsforskning. 37:1993;150-155.
22. Giles W.H., Kittner S.J., Anda R.F., Croft J.B., Casper M.L. Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidmiologic follow-up study. Stroke. 26:1995;1166-1170.
23. Stampfer M.J., Malinow M.R., Willett W.C. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in United States physicians. JAMA. 268:1992;877-881.
24. Herbert V Development of human folate deficiency. Picciano M.F., Stokstad E.L.R., Gregory II J.F. Folic acid metabolism in health and disease. 1990;195-210 Wiley-Liss, Inc.
25. Hoffbrand A.V., Newcombe B.F.A., Mollin D.L. Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Path. 19:1966;17-28.
26. Chanarin I. The megaloblastic anaemias. 2nd ed:1979;Blackwell Scientific Publications, Oxford.
27. Life Sciences Research Office. Assessement of folate methodology used in the third National Health and Nutrition Examination survey (NHANES III, 1988-1994). 1994.
28. Shane B., Tamura T., Stokstad E.L.R. Folate assay: a comparison of radioassay and microbiological methods. Clin Chim Acta. 100:1980;13-19.
29. Magnus E. Behandler du dine vitamin-B12 pasienter korrekt? Tidsskr Nor Lægeforen. 22:1996;2711.
30. Bergmark C., Mansoor M.A., Swedenborg J., de Faire U., Svardal A.M., Ueland P.M. Hyperhomocysteinemia in patients operated for lower extremity ischemia below the age of 50. Effect of smoking and extent of disease. Eur J Vasc Surg. 7:1993;391-396.
31. Piyathilake C.J., Macaluso M., Hine R.J., Richards E.W., Krumdieck C.L. Local and systemic effects of cigarette smoking on folate and vitamin-B12. Am J Clin Nutr. 60:1994;559-566.
32. Vermaak W.J.H., Ubbink J.B., Barnard H.C., Potgieter G.M., van Jaarsveld H., Groenewald A.J. Vitamin B-6 nutrition status and cigarette smoking. Am J Clin Nutr. 51:1990;1058-1061.
33. McPhillips J.B., Eaton C.B., Gans K.M. et al. Dietary differences in smokers and nonsmokers from two southeastern New England communities. J Am Diet Assoc. 3:1994;287-292.
34. Subar A.F., Harlan L.C., Mattson M.E. Food and nutrient intake differences between smokers and nonsmokers in the United States. Am J Public Health. 80:1990;1323-1329.
35. Giovanucci E., Rimm E.B., Ascherio A., Stampfer M.J., Colditz G.A., Willett W.C. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 87:1995;265-273.
36. Butterworth C.E.J. Effect of folate on cervical cancer. Synergism among risk factors. Ann NY Acad Sci. 669:1992;293-299.
37. Saito M., Harubumi K., Tsuchida T., Konaka C. Chemoprevention effects on bronchial squamous metaplasia by folate and vitamin B12 in heavy smokers. Chest. 105:1994;496-499.
38. Daly L.E., Kirke P.N., Molloy A., Weir D.G., Scott J.M. Folate levels and neural tube defects. JAMA. 274:1995;1698-1702.
39. Mitchell L.E., Duffy D.L., Duffy P., Bellingham G., Martin N.G. Genetic effects on variation in red-blood-cell folate in adults: implications for the familial aggregation of neural tube defects. Am J Hum Genet. 60:1997;433-438.
40. Caroll K.K., Kurowska E.M. Soy consumption and cholesterol reduction: review of animal and human studies. J Nutr. 125:1995;594S-597S.
41. Arnadottir M., Brattstrøm L., Simonsen O. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentations in dialysis patients. Clin Nephrol. 40:1993;236-240.
42. Sermet A., Aybak M., Ulak G., Güzel C., Denli O. Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists. Arztneimittelforschung. 45:1995;19-21.
43. Superko H.R. Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia. Am J Cardiol. 79:1997;705-706.
44. Young P.B., Kennedy S., Molloy A.M., Scott J.M., Weir D.G., Kennedy D.G. Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs. Atherosclerosis. 129:1997;67-71.
45. Lynch S.M., Frei B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta. 1345:1997;215-221.
46. Halvorsen B., Brude I., Drevon C.A. et al. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J Lipid Res. 37:1996;1591-1600.
47. Kwiterovich P.O. Jr. The effect of dietary fat, antioxidants, and pro-oxidants on blood lipids, lipoproteins, and atherosclerosis. J Am Diet Assoc. 97(Suppl):1997;S31-41.
48. Lebuffe G. et al. Endothelial derived vasorelaxation is impaired in human APOA-1 transgenic rabbits. Biochem Biophys Res Commun. 241:1997;205-211.
49. Tawakol A., Omland T., Gerhard M., Wu J.T., Creager M.A. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 95:1997;1119-1121.
50. Egerton W., Silberberg J., Crooks R., Ray C., Xie L., Dudman N. Serial measures of plasma homocyst(e)ine after acute myocardial infarction. Am J Cardiol. 77:1996;759-761.
51. Rosenson R.S. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol. 22:1993;933-940.
52. Andreassen A.K., Berg K., Torsvik H. Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction. Clin Genet. 46:1994;410-416.